Global Deferiprone Market Research Report 2021

SKU ID : QYR- 17783364

Publishing Date : 23-Mar-2021

No. of pages : 97

PRICE
2900
4350
5800

  • Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload.
    Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. Those two totally got about 96% market shares.
    North America is the largest consumption region of Deferiprone, with a consumption value market share nearly 28%. Europe is the second largest consumption region of deferiprone, enjoying consumption value market share nearly 24%.

    The global Deferiprone market was valued at US$ 35 million in 2020 and is expected to reach US$ 38 million by the end of 2027, growing at a CAGR of 0.9% during 2021-2027.
    This report focuses on Deferiprone volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Deferiprone market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

    Global Deferiprone Market: Segment Analysis
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Tablet
    Oral Solution
    Capsule

    Segment by Application
    Transfusional Iron Overload
    NTDT Caused Iron Overload

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Apotex
    Cipla

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports